As of 2025-07-03, the Intrinsic Value of Meridian Bioscience Inc (VIVO) is 31.74 USD. This VIVO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 33.97 USD, the upside of Meridian Bioscience Inc is -6.60%.
The range of the Intrinsic Value is 21.65 - 64.30 USD
Based on its market price of 33.97 USD and our intrinsic valuation, Meridian Bioscience Inc (VIVO) is overvalued by 6.60%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 21.65 - 64.30 | 31.74 | -6.6% |
| DCF (Growth 10y) | 24.19 - 67.58 | 34.56 | 1.7% |
| DCF (EBITDA 5y) | 28.16 - 34.20 | 30.77 | -9.4% |
| DCF (EBITDA 10y) | 30.43 - 40.76 | 34.91 | 2.8% |
| Fair Value | 22.40 - 22.40 | 22.40 | -34.07% |
| P/E | 33.05 - 34.35 | 33.84 | -0.4% |
| EV/EBITDA | 18.75 - 35.26 | 28.17 | -17.1% |
| EPV | 15.63 - 22.03 | 18.83 | -44.6% |
| DDM - Stable | 8.69 - 35.66 | 22.18 | -34.7% |
| DDM - Multi | 15.11 - 50.19 | 23.47 | -30.9% |
| Market Cap (mil) | 1,494.96 |
| Beta | 0.23 |
| Outstanding shares (mil) | 44.01 |
| Enterprise Value (mil) | 1,438.51 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.10% |
| Cost of Debt | 4.25% |
| WACC | 9.01% |